首页 > 最新文献

Current Opinion in Obstetrics & Gynecology最新文献

英文 中文
Mesothelin in solid tumors: biology, biomarker utility, and therapeutic targeting. 实体肿瘤中的间皮素:生物学、生物标志物效用和治疗靶向。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-10 DOI: 10.1097/GCO.0000000000001083
Ilary Ruscito, Elizaveta Baisheva, Eliane T Taube, E Ioana Braicu

Purpose of review: Mesothelin (MSLN) is a CA125-binding surface glycoprotein that mediates cell adhesion and peritoneal metastasis development in mesothelioma, high-grade serous ovarian cancer (HGSOC), pancreatic ductal adenocarcinoma, and cholangiocarcinoma.

Recent findings: Because of its tumor-restricted expression and functional role in dissemination, MSLN is represents an attractive molecule to target in solid tumors. Several antibody-based therapeutic agents, vaccine and chimeric antigen receptor therapy directed against MSLN are object of clinical evaluation. MSLN-targeted therapies are limited by antigen shedding and on-target/off-target effects.

Summary: MSLN is expressed in solid tumor patients, with no differences in expression among histologies. MSLN expression is associated with Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stage and platinum sensitivity. Higher MSLN expression is detected among primary ovarian cancer patients and correlates with better survival data in HGSOC patients only. According to our data, treatment strategies targeting MSLN should be offered in first line setting rather than in relapse.

综述目的:间皮素(MSLN)是一种ca125结合表面糖蛋白,在间皮瘤、高级别浆液性卵巢癌(HGSOC)、胰腺导管腺癌和胆管癌中介导细胞粘附和腹膜转移发展。最近发现:由于其肿瘤限制性表达和在传播中的功能作用,MSLN在实体肿瘤中是一种有吸引力的靶向分子。针对MSLN的几种基于抗体的治疗药物、疫苗和嵌合抗原受体治疗是临床评估的对象。msln靶向治疗受到抗原脱落和靶标/脱靶效应的限制。总结:MSLN在实体瘤患者中表达,在不同组织中表达无差异。MSLN的表达与FIGO阶段和铂敏感性有关。在原发性卵巢癌患者中检测到较高的MSLN表达,并且仅在HGSOC患者中与更好的生存数据相关。根据我们的数据,针对MSLN的治疗策略应该在一线而不是复发时提供。
{"title":"Mesothelin in solid tumors: biology, biomarker utility, and therapeutic targeting.","authors":"Ilary Ruscito, Elizaveta Baisheva, Eliane T Taube, E Ioana Braicu","doi":"10.1097/GCO.0000000000001083","DOIUrl":"https://doi.org/10.1097/GCO.0000000000001083","url":null,"abstract":"<p><strong>Purpose of review: </strong>Mesothelin (MSLN) is a CA125-binding surface glycoprotein that mediates cell adhesion and peritoneal metastasis development in mesothelioma, high-grade serous ovarian cancer (HGSOC), pancreatic ductal adenocarcinoma, and cholangiocarcinoma.</p><p><strong>Recent findings: </strong>Because of its tumor-restricted expression and functional role in dissemination, MSLN is represents an attractive molecule to target in solid tumors. Several antibody-based therapeutic agents, vaccine and chimeric antigen receptor therapy directed against MSLN are object of clinical evaluation. MSLN-targeted therapies are limited by antigen shedding and on-target/off-target effects.</p><p><strong>Summary: </strong>MSLN is expressed in solid tumor patients, with no differences in expression among histologies. MSLN expression is associated with Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stage and platinum sensitivity. Higher MSLN expression is detected among primary ovarian cancer patients and correlates with better survival data in HGSOC patients only. According to our data, treatment strategies targeting MSLN should be offered in first line setting rather than in relapse.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145716852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The new age of periviability. 新的生存时代。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-15 DOI: 10.1097/GCO.0000000000001061
Amythis Soltani, Anne R Waldrop, Andrea Henkel

Purpose of review: This review focuses on the clinical and ethical complexities of managing pregnancies between 20 and 25 weeks and 6 days of gestation, known as periviability, where fetal survival is uncertain and viability cannot be uniformly defined.

Recent findings: Recent literature highlights that outcomes during periviability depend on a constellation of factors, including gestational age, fetal weight, institutional resources, and access to neonatal intensive care. Advances in neonatal and obstetric care have pushed the threshold of viability earlier, but survival and morbidity remain highly variable. The diagnosis of life-limiting fetal anomalies or severe maternal complications during this time frequently necessitates urgent decision-making around abortion. Legal changes post- Dobbs have further complicated access to abortion care. Additionally, new recommendations surrounding feticidal injection are highlighted. Studies also emphasize that parental decisions are guided more by intuitive beliefs than by statistics alone, underscoring the importance of values-based counseling.

Summary: Periviability challenges clinicians to balance medical, legal, and ethical considerations while supporting patients through highly individualized, time-sensitive decisions. A shared decision-making model grounded in ethical principles is essential. Ongoing dialogue and refined, patient-centered guidelines are needed to ensure compassionate, equitable, and evidence-based care at the threshold of viability.

综述目的:本综述的重点是处理妊娠20 - 25周6天的临床和伦理复杂性,称为围生期,胎儿存活不确定,生存能力不能统一定义。最近的发现:最近的文献强调,围生期的结果取决于一系列因素,包括胎龄、胎儿体重、机构资源和获得新生儿重症监护。新生儿和产科护理的进步将生存能力的门槛提前了,但存活率和发病率仍然高度可变。在此期间,诊断出限制生命的胎儿异常或严重的产妇并发症往往需要围绕堕胎做出紧急决策。多布斯事件后的法律变化使堕胎护理的获取更加复杂。此外,还强调了关于注射杀胎的新建议。研究还强调,父母的决定更多地受到直觉信念的指导,而不仅仅是统计数据,这强调了基于价值观的咨询的重要性。摘要:临近生存期挑战临床医生平衡医疗,法律和伦理方面的考虑,同时支持患者通过高度个性化,时间敏感的决定。基于道德原则的共同决策模式至关重要。需要持续的对话和完善的、以患者为中心的指南,以确保在生存能力的门槛上提供富有同情心、公平和循证的护理。
{"title":"The new age of periviability.","authors":"Amythis Soltani, Anne R Waldrop, Andrea Henkel","doi":"10.1097/GCO.0000000000001061","DOIUrl":"10.1097/GCO.0000000000001061","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review focuses on the clinical and ethical complexities of managing pregnancies between 20 and 25 weeks and 6 days of gestation, known as periviability, where fetal survival is uncertain and viability cannot be uniformly defined.</p><p><strong>Recent findings: </strong>Recent literature highlights that outcomes during periviability depend on a constellation of factors, including gestational age, fetal weight, institutional resources, and access to neonatal intensive care. Advances in neonatal and obstetric care have pushed the threshold of viability earlier, but survival and morbidity remain highly variable. The diagnosis of life-limiting fetal anomalies or severe maternal complications during this time frequently necessitates urgent decision-making around abortion. Legal changes post- Dobbs have further complicated access to abortion care. Additionally, new recommendations surrounding feticidal injection are highlighted. Studies also emphasize that parental decisions are guided more by intuitive beliefs than by statistics alone, underscoring the importance of values-based counseling.</p><p><strong>Summary: </strong>Periviability challenges clinicians to balance medical, legal, and ethical considerations while supporting patients through highly individualized, time-sensitive decisions. A shared decision-making model grounded in ethical principles is essential. Ongoing dialogue and refined, patient-centered guidelines are needed to ensure compassionate, equitable, and evidence-based care at the threshold of viability.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"397-402"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of office-based ultrasound in family planning practice. 办公室超声在计划生育实践中的作用。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-15 DOI: 10.1097/GCO.0000000000001062
Jayne Caron, Jade M Shorter

Purpose of review: This review highlights the evolving role of ultrasound in family planning clinics. Given the increasing complexity of contraceptive management, abortion care, and early pregnancy assessments, understanding the utility of both traditional and point-of-care ultrasound (POCUS) is timely and relevant for improving patient outcomes and enhancing clinical efficiency.

Recent findings: The literature indicates that ultrasound significantly aids in intrauterine device (IUD) placement, localization, and removal, particularly with challenging anatomy. Studies suggest that ultrasound guidance can reduce procedure times, pain, and complications associated with IUD insertions. In addition, the review discusses the role of ultrasound in nonpalpable contraceptive implant removals and the use of ultrasound in abortion care, where it may enhance safety and efficacy. Early pregnancy assessments using ultrasound are also reviewed, with findings supporting its use in diagnosing ectopic pregnancies and early pregnancy loss.

Summary: The findings highlight the importance of integrating ultrasound into routine clinical practice for family planning and early pregnancy care. By facilitating rapid diagnosis and management within a single visit, POCUS can potentially reduce emergency department utilization and improve patient satisfaction. Future research should focus on standardizing ultrasound protocols and exploring its broader applications in reproductive health to further enhance clinical outcomes.

综述目的:本文综述了超声在计划生育诊所中的作用。鉴于避孕管理、流产护理和早期妊娠评估的复杂性日益增加,了解传统和即时超声(POCUS)的效用对于改善患者预后和提高临床效率是及时和相关的。最近的发现:文献表明,超声在宫内节育器(IUD)的放置,定位和取出,特别是具有挑战性的解剖中有显著的帮助。研究表明,超声引导可以减少手术时间、疼痛和与宫内节育器插入相关的并发症。此外,本文还讨论了超声在不可触及的避孕植入物移除中的作用,以及超声在流产护理中的应用,超声可以提高安全性和有效性。使用超声进行早期妊娠评估也进行了回顾,研究结果支持其在诊断异位妊娠和早期妊娠丢失中的应用。总结:研究结果强调了将超声纳入计划生育和早期妊娠护理的常规临床实践的重要性。通过在一次就诊中促进快速诊断和管理,POCUS可以潜在地减少急诊科的利用率并提高患者满意度。未来的研究应着眼于规范超声方案,探索其在生殖健康方面的更广泛应用,以进一步提高临床效果。
{"title":"The role of office-based ultrasound in family planning practice.","authors":"Jayne Caron, Jade M Shorter","doi":"10.1097/GCO.0000000000001062","DOIUrl":"10.1097/GCO.0000000000001062","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights the evolving role of ultrasound in family planning clinics. Given the increasing complexity of contraceptive management, abortion care, and early pregnancy assessments, understanding the utility of both traditional and point-of-care ultrasound (POCUS) is timely and relevant for improving patient outcomes and enhancing clinical efficiency.</p><p><strong>Recent findings: </strong>The literature indicates that ultrasound significantly aids in intrauterine device (IUD) placement, localization, and removal, particularly with challenging anatomy. Studies suggest that ultrasound guidance can reduce procedure times, pain, and complications associated with IUD insertions. In addition, the review discusses the role of ultrasound in nonpalpable contraceptive implant removals and the use of ultrasound in abortion care, where it may enhance safety and efficacy. Early pregnancy assessments using ultrasound are also reviewed, with findings supporting its use in diagnosing ectopic pregnancies and early pregnancy loss.</p><p><strong>Summary: </strong>The findings highlight the importance of integrating ultrasound into routine clinical practice for family planning and early pregnancy care. By facilitating rapid diagnosis and management within a single visit, POCUS can potentially reduce emergency department utilization and improve patient satisfaction. Future research should focus on standardizing ultrasound protocols and exploring its broader applications in reproductive health to further enhance clinical outcomes.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"403-408"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144857095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First-trimester medication abortion: anemia and blood loss. 妊娠早期药物流产:贫血和失血。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-20 DOI: 10.1097/GCO.0000000000001063
Lucy Rose, Sarah Putnam, Eve Espey

Purpose of review: Although ample evidence demonstrates the safety and effectiveness of medication abortion, its safety in individuals with anemia is not well understood; modern literature describing quantitative blood loss from medication abortion is limited. As medication abortion is increasingly utilized, reviewing current guidelines and literature related to anemia and blood loss from medication abortion may help inform practice and future research.

Recent findings: Guidelines have not established a safe minimum level of starting hemoglobin for medication abortion or a single standard for the provision of medication abortion in the setting of anemia. Studies assessing blood loss from early medication abortion report a low mean decrease in hemoglobin (0.1-0.7 g/dl); however, these studies used a variety of medication regimens, and most exclude individuals with significant anemia (hemoglobin < 9.5-10 g/dl) and gestational duration greater than 63 days.

Summary: Communities most severely impacted by abortion restrictions and bans also experience significantly higher rates of anemia. Guidelines that restrict medication abortion to patients who meet arbitrary hemoglobin cutoffs can lead to delays and barriers to care. Studies using current medication regimens and including patients with moderate-to-severe anemia and gestational duration greater than 63 days are needed to inform eligibility and safety, and support provider buy-in and equity.

综述目的:虽然有充分的证据表明药物流产的安全性和有效性,但其在贫血患者中的安全性尚不清楚;现代文献描述定量失血药物流产是有限的。随着药物流产的应用越来越多,回顾与药物流产引起的贫血和失血相关的现行指南和文献可能有助于为实践和未来的研究提供信息。最近的发现:指南没有建立药物流产起始血红蛋白的最低安全水平,也没有在贫血情况下提供药物流产的单一标准。评估早期药物流产失血量的研究报告血红蛋白平均降低较低(0.1-0.7 g/dl);然而,这些研究使用了多种药物方案,并且大多数排除了明显贫血(血红蛋白< 9.5-10 g/dl)和妊娠期大于63天的个体。摘要:受堕胎限制和禁令影响最严重的社区贫血率也明显较高。将药物流产限制在满足任意血红蛋白临界值的患者的指导方针可能导致延误和护理障碍。需要使用目前的药物方案并纳入妊娠期大于63天的中度至重度贫血患者进行研究,以告知资格和安全性,并支持提供者的支持和公平。
{"title":"First-trimester medication abortion: anemia and blood loss.","authors":"Lucy Rose, Sarah Putnam, Eve Espey","doi":"10.1097/GCO.0000000000001063","DOIUrl":"10.1097/GCO.0000000000001063","url":null,"abstract":"<p><strong>Purpose of review: </strong>Although ample evidence demonstrates the safety and effectiveness of medication abortion, its safety in individuals with anemia is not well understood; modern literature describing quantitative blood loss from medication abortion is limited. As medication abortion is increasingly utilized, reviewing current guidelines and literature related to anemia and blood loss from medication abortion may help inform practice and future research.</p><p><strong>Recent findings: </strong>Guidelines have not established a safe minimum level of starting hemoglobin for medication abortion or a single standard for the provision of medication abortion in the setting of anemia. Studies assessing blood loss from early medication abortion report a low mean decrease in hemoglobin (0.1-0.7 g/dl); however, these studies used a variety of medication regimens, and most exclude individuals with significant anemia (hemoglobin < 9.5-10 g/dl) and gestational duration greater than 63 days.</p><p><strong>Summary: </strong>Communities most severely impacted by abortion restrictions and bans also experience significantly higher rates of anemia. Guidelines that restrict medication abortion to patients who meet arbitrary hemoglobin cutoffs can lead to delays and barriers to care. Studies using current medication regimens and including patients with moderate-to-severe anemia and gestational duration greater than 63 days are needed to inform eligibility and safety, and support provider buy-in and equity.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"387-396"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraception in transgender and gender diverse patients. 跨性别和性别差异患者的避孕。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-16 DOI: 10.1097/GCO.0000000000001066
Megan McCracken, Nichole Tyson

Purpose of review: Transgender and gender diverse (TGD) individuals assigned female at birth have specific contraceptive needs that are often unmet. This can be because of bias, systemic barriers, and misinformation as this field continues to grow. As the TGD population increases, there remains a need for evidence-based guidance on gender-affirming, comprehensive contraceptive counseling.

Recent findings: TGD patients may pursue contraception for pregnancy prevention, menstrual suppression, or gender affirmation. Testosterone is not an approved form of contraception, so TGD patients on testosterone may choose other hormonal contraceptive options with side effects that may help alleviate gender dysphoria. Limited provider training and structural obstacles, such as insurance limitations and gendered clinical environments, continue to be barriers to care. Appropriate TGD care involves a trauma-informed, autonomy-centered approach to contraceptive counseling.

Summary: Providing high-quality contraceptive care to TGD patients requires individualized, affirming, and evidence-based counseling. Understanding the interaction between gender identity, reproductive goals, and contraceptive methods is essential. Clinicians must adopt inclusive practices and advocate for expanded research and policy reform to reduce disparities and support reproductive autonomy for TGD individuals.

回顾目的:变性和性别多样化(TGD)个体在出生时被指定为女性,有特殊的避孕需求,往往没有得到满足。这可能是由于偏见、系统性障碍以及随着这一领域的不断发展而产生的错误信息。随着TGD人口的增加,仍然需要在性别确认和全面避孕咨询方面提供循证指导。近期研究发现:TGD患者可能为了预防妊娠、抑制月经或肯定性别而采取避孕措施。睾酮并不是一种被批准的避孕方法,所以服用睾酮的TGD患者可能会选择其他有副作用的激素避孕方法,这可能有助于缓解性别焦虑。有限的提供者培训和结构性障碍,如保险限制和性别差异的临床环境,仍然是护理的障碍。适当的TGD护理包括创伤知情,自主为中心的避孕咨询方法。摘要:为TGD患者提供高质量的避孕护理需要个性化的、肯定的和基于证据的咨询。了解性别认同、生殖目标和避孕方法之间的相互作用至关重要。临床医生必须采取包容的做法,倡导扩大研究和政策改革,以减少差距,支持TGD患者的生殖自主权。
{"title":"Contraception in transgender and gender diverse patients.","authors":"Megan McCracken, Nichole Tyson","doi":"10.1097/GCO.0000000000001066","DOIUrl":"10.1097/GCO.0000000000001066","url":null,"abstract":"<p><strong>Purpose of review: </strong>Transgender and gender diverse (TGD) individuals assigned female at birth have specific contraceptive needs that are often unmet. This can be because of bias, systemic barriers, and misinformation as this field continues to grow. As the TGD population increases, there remains a need for evidence-based guidance on gender-affirming, comprehensive contraceptive counseling.</p><p><strong>Recent findings: </strong>TGD patients may pursue contraception for pregnancy prevention, menstrual suppression, or gender affirmation. Testosterone is not an approved form of contraception, so TGD patients on testosterone may choose other hormonal contraceptive options with side effects that may help alleviate gender dysphoria. Limited provider training and structural obstacles, such as insurance limitations and gendered clinical environments, continue to be barriers to care. Appropriate TGD care involves a trauma-informed, autonomy-centered approach to contraceptive counseling.</p><p><strong>Summary: </strong>Providing high-quality contraceptive care to TGD patients requires individualized, affirming, and evidence-based counseling. Understanding the interaction between gender identity, reproductive goals, and contraceptive methods is essential. Clinicians must adopt inclusive practices and advocate for expanded research and policy reform to reduce disparities and support reproductive autonomy for TGD individuals.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"376-386"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraception in the setting of gynecologic and breast dysplasia. 避孕在妇科和乳腺发育不良的设置。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-28 DOI: 10.1097/GCO.0000000000001059
Isabel Beshar, Lauren J Tostrud, Talayeh Ghezelayagh, Paul D Blumenthal

Purpose of review: There is limited data on contraceptive options in the setting of gynecologic and breast dysplasia. Despite this, many patients who report a history of these precancers retain their reproductive organs and seek contraception to avoid pregnancy. These patients require evidence-based counseling to guide their contraceptive choices, particularly in the setting of hormonally driven pathology.

Recent findings: In this review article, we outline known data on contraceptive options for patients with borderline ovarian tumors, endometrial hyperplasia, cervical/vulvar dysplasia, and atypical lobular and ductal hyperplasia. We also identify gaps in knowledge and opportunities for further research.

Summary: Patients with gynecologic and breast dysplasia benefit from comprehensive contraception counseling. More research is needed on contraceptive options for patients with dysplasia.

综述目的:关于妇科和乳腺发育不良患者的避孕选择的数据有限。尽管如此,许多报告有癌前病变史的患者保留了生殖器官,并寻求避孕以避免怀孕。这些患者需要以证据为基础的咨询,以指导他们的避孕选择,特别是在激素驱动的病理设置。最近发现:在这篇综述文章中,我们概述了交界性卵巢肿瘤、子宫内膜增生、宫颈/外阴发育不良、非典型小叶和导管增生患者的避孕选择的已知数据。我们还发现了知识上的差距和进一步研究的机会。总结:妇科和乳腺发育不良患者可从全面的避孕咨询中获益。需要对不典型增生患者的避孕选择进行更多的研究。
{"title":"Contraception in the setting of gynecologic and breast dysplasia.","authors":"Isabel Beshar, Lauren J Tostrud, Talayeh Ghezelayagh, Paul D Blumenthal","doi":"10.1097/GCO.0000000000001059","DOIUrl":"10.1097/GCO.0000000000001059","url":null,"abstract":"<p><strong>Purpose of review: </strong>There is limited data on contraceptive options in the setting of gynecologic and breast dysplasia. Despite this, many patients who report a history of these precancers retain their reproductive organs and seek contraception to avoid pregnancy. These patients require evidence-based counseling to guide their contraceptive choices, particularly in the setting of hormonally driven pathology.</p><p><strong>Recent findings: </strong>In this review article, we outline known data on contraceptive options for patients with borderline ovarian tumors, endometrial hyperplasia, cervical/vulvar dysplasia, and atypical lobular and ductal hyperplasia. We also identify gaps in knowledge and opportunities for further research.</p><p><strong>Summary: </strong>Patients with gynecologic and breast dysplasia benefit from comprehensive contraception counseling. More research is needed on contraceptive options for patients with dysplasia.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"370-375"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary genitourinary fistula management: treatment, trends, and innovations. 当代泌尿生殖系统瘘管管理:治疗,趋势和创新。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-28 DOI: 10.1097/GCO.0000000000001065
Nancy Wei, Courtney Pfeuti, Brian J Linder

Purpose of review: To synthesize the current literature regarding the evaluation and management of genitourinary fistula in women.

Recent findings: Genitourinary fistula are aberrant communications between the urinary tract and genital tract that present with urinary leakage per the vagina. Initial management often involves conservative measures, such as urethral catheter or ureteral stent placement, progressing to surgical repair when needed. Key surgical principles include a tension-free, watertight closure with well-vascularized tissue including tissue interposition as appropriate, and postoperative urinary drainage. When surgical management of vesicovaginal fistula is necessary, a transvaginal repair is the most common. Other minimally invasive approaches are increasing and result in similarly high success rates with lower patient morbidity compared to open abdominal surgeries. The initial management of ureterovaginal fistula commonly includes ureteral stent placement. When not feasible or in persistent fistula, laparoscopic and robotic surgical repair with ureteral reconstruction offers high success rates with lower morbidity than an open approach.

Summary: Successful management of genitourinary fistula ranges from conservative urinary tract drainage to surgical interventions based on etiology, location, and complexity. Approaches to repair are shifting toward less invasive procedures. With optimal technique and surgical planning, high success rates can be achieved, particularly in primary repairs.

综述目的:综合目前有关女性泌尿生殖系统瘘的评价和治疗的文献。泌尿生殖系统瘘是泌尿道和生殖道之间的异常通信,通过阴道出现尿漏。最初的治疗通常包括保守措施,如放置尿道导管或输尿管支架,必要时进行手术修复。关键的手术原则包括无张力、水密闭合和血管化良好的组织,包括适当的组织介入,以及术后尿路引流。当膀胱阴道瘘的手术治疗是必要的,经阴道修复是最常见的。其他微创方法也在不断增加,与腹部手术相比,成功率高,患者发病率低。输尿管阴道瘘的初始治疗通常包括输尿管支架置入。当不可行或存在持续性瘘管时,腹腔镜和机器人输尿管重建手术比开放手术成功率高,发病率低。总结:根据病因、位置和复杂性,成功的泌尿生殖系统瘘的治疗范围从保守的尿路引流到手术干预。修复方法正在转向侵入性较小的手术。通过最佳的技术和手术计划,可以获得很高的成功率,特别是在初级修复中。
{"title":"Contemporary genitourinary fistula management: treatment, trends, and innovations.","authors":"Nancy Wei, Courtney Pfeuti, Brian J Linder","doi":"10.1097/GCO.0000000000001065","DOIUrl":"10.1097/GCO.0000000000001065","url":null,"abstract":"<p><strong>Purpose of review: </strong>To synthesize the current literature regarding the evaluation and management of genitourinary fistula in women.</p><p><strong>Recent findings: </strong>Genitourinary fistula are aberrant communications between the urinary tract and genital tract that present with urinary leakage per the vagina. Initial management often involves conservative measures, such as urethral catheter or ureteral stent placement, progressing to surgical repair when needed. Key surgical principles include a tension-free, watertight closure with well-vascularized tissue including tissue interposition as appropriate, and postoperative urinary drainage. When surgical management of vesicovaginal fistula is necessary, a transvaginal repair is the most common. Other minimally invasive approaches are increasing and result in similarly high success rates with lower patient morbidity compared to open abdominal surgeries. The initial management of ureterovaginal fistula commonly includes ureteral stent placement. When not feasible or in persistent fistula, laparoscopic and robotic surgical repair with ureteral reconstruction offers high success rates with lower morbidity than an open approach.</p><p><strong>Summary: </strong>Successful management of genitourinary fistula ranges from conservative urinary tract drainage to surgical interventions based on etiology, location, and complexity. Approaches to repair are shifting toward less invasive procedures. With optimal technique and surgical planning, high success rates can be achieved, particularly in primary repairs.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"432-437"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144979607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social and clinical science discovery in family planning: the data keep coming. 计划生育的社会和临床科学发现:数据不断涌现。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-28 DOI: 10.1097/GCO.0000000000001071
Paul D Blumenthal
{"title":"Social and clinical science discovery in family planning: the data keep coming.","authors":"Paul D Blumenthal","doi":"10.1097/GCO.0000000000001071","DOIUrl":"https://doi.org/10.1097/GCO.0000000000001071","url":null,"abstract":"","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"37 6","pages":"367-369"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
#Birth control: contraception conversations on social media. #生育控制:社交媒体上的避孕对话。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-12 DOI: 10.1097/GCO.0000000000001070
Jayne Caron, Erica P Cahill

Purpose of review: Social networks, now including social media platforms, are increasingly important sources of health information for many patients, particularly patients of reproductive age. Observing and understanding conversations about contraception happening on social media can help clinicians address patient concerns and misinformation.

Recent findings: Studies evaluating social media posts on contraception have found the most popular methods discussed across platforms are intrauterine devices and oral contraceptive pills. Side effects are the most frequently discussed topic on all social media formats, with negative effects discussed much more frequently than benefits. People viewing social media are often more drawn to posts around the logistics of contraception. Most videos are created by nonhealthcare professionals and are more likely to contain misinformation than videos created by healthcare professionals.

Summary: Social media is an important tool that patients are using to access information about contraception. Physicians and clinicians should understand the themes patients are discussing so that they can address them in counseling. Physicians, clinicians, and healthcare organizations should consider contributing high-quality information to social media to improve accuracy and counter misinformation.

综述目的:社交网络,现在包括社交媒体平台,对许多患者,特别是育龄患者来说,是越来越重要的健康信息来源。观察和理解社交媒体上关于避孕的对话可以帮助临床医生解决患者的担忧和错误信息。最近的发现:对社交媒体上有关避孕的帖子进行评估的研究发现,平台上讨论最多的避孕方法是宫内节育器和口服避孕药。副作用是所有社交媒体形式中最常讨论的话题,负面影响的讨论频率远高于益处。浏览社交媒体的人往往更容易被有关避孕后勤的帖子所吸引。大多数视频是由非医疗保健专业人员创建的,比医疗保健专业人员创建的视频更有可能包含错误信息。摘要:社交媒体是患者获取避孕信息的重要工具。医生和临床医生应该了解患者正在讨论的主题,以便他们可以在咨询中解决这些问题。医生、临床医生和医疗保健组织应该考虑向社交媒体提供高质量的信息,以提高准确性并打击错误信息。
{"title":"#Birth control: contraception conversations on social media.","authors":"Jayne Caron, Erica P Cahill","doi":"10.1097/GCO.0000000000001070","DOIUrl":"10.1097/GCO.0000000000001070","url":null,"abstract":"<p><strong>Purpose of review: </strong>Social networks, now including social media platforms, are increasingly important sources of health information for many patients, particularly patients of reproductive age. Observing and understanding conversations about contraception happening on social media can help clinicians address patient concerns and misinformation.</p><p><strong>Recent findings: </strong>Studies evaluating social media posts on contraception have found the most popular methods discussed across platforms are intrauterine devices and oral contraceptive pills. Side effects are the most frequently discussed topic on all social media formats, with negative effects discussed much more frequently than benefits. People viewing social media are often more drawn to posts around the logistics of contraception. Most videos are created by nonhealthcare professionals and are more likely to contain misinformation than videos created by healthcare professionals.</p><p><strong>Summary: </strong>Social media is an important tool that patients are using to access information about contraception. Physicians and clinicians should understand the themes patients are discussing so that they can address them in counseling. Physicians, clinicians, and healthcare organizations should consider contributing high-quality information to social media to improve accuracy and counter misinformation.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"409-415"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicompartment pelvic floor prolapse: advances in diagnosis and surgical management. 多腔室盆底脱垂:诊断和手术治疗的进展。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-16 DOI: 10.1097/GCO.0000000000001069
Shannon L Wallace, Amy D Gee, Deepanjana Das

Purpose of review: Multicompartment pelvic organ prolapse, including concurrent rectal and vaginal prolapse, is increasingly recognized in aging populations. This review summarizes recent advances in diagnostic imaging, multidisciplinary evaluation, and surgical techniques for combined repair.

Recent findings: Multicompartment prolapse is increasingly prevalent and often underrecognized without coordinated evaluation. Dynamic defecography, particularly upright or MRI-based, improves detection of multicompartment descent. Minimally invasive combined sacrocolpopexy (SCP) and ventral mesh rectopexy (VMR) is increasingly used with favorable outcomes. Surgical series report low complication rates and suggest a potential reduction in prolapse recurrence with combined repair. Robotic platforms, including newer systems, enhance precision, and visualization. Emerging techniques include laparoscopic resection rectopexy with SCP and selective use of biologic mesh. Multidisciplinary care improves coordination and recurrence prevention.

Summary: Contemporary management of multicompartment prolapse requires a collaborative, patient-centered approach. Advances in imaging and minimally invasive surgery, particularly robotic SCP and VMR, have improved outcomes. Future research should focus on standardizing techniques, optimizing mesh configurations, and long-term functional results.

综述目的:多腔室盆腔器官脱垂,包括直肠脱垂和阴道脱垂,在老年人中越来越被认识到。本文综述了联合修复在诊断成像、多学科评估和手术技术方面的最新进展。最近的发现:多室脱垂越来越普遍,经常被忽视,没有协调的评估。动态排便造影,特别是直立或基于核磁共振成像,提高了多室下降的检测。微创骶colpop固定术(SCP)和腹侧网状直肠固定术(VMR)的应用越来越广泛,效果良好。外科系列报道低并发症发生率,并提示联合修复可能减少脱垂复发。机器人平台,包括更新的系统,提高了精度和可视化。新兴技术包括腹腔镜直肠固定术和选择性使用生物补片。多学科治疗改善协调和复发预防。摘要:当代多室脱垂的治疗需要协作,以患者为中心的方法。成像和微创手术的进步,特别是机器人SCP和VMR,改善了结果。未来的研究应集中在标准化技术、优化网格结构和长期功能结果上。
{"title":"Multicompartment pelvic floor prolapse: advances in diagnosis and surgical management.","authors":"Shannon L Wallace, Amy D Gee, Deepanjana Das","doi":"10.1097/GCO.0000000000001069","DOIUrl":"10.1097/GCO.0000000000001069","url":null,"abstract":"<p><strong>Purpose of review: </strong>Multicompartment pelvic organ prolapse, including concurrent rectal and vaginal prolapse, is increasingly recognized in aging populations. This review summarizes recent advances in diagnostic imaging, multidisciplinary evaluation, and surgical techniques for combined repair.</p><p><strong>Recent findings: </strong>Multicompartment prolapse is increasingly prevalent and often underrecognized without coordinated evaluation. Dynamic defecography, particularly upright or MRI-based, improves detection of multicompartment descent. Minimally invasive combined sacrocolpopexy (SCP) and ventral mesh rectopexy (VMR) is increasingly used with favorable outcomes. Surgical series report low complication rates and suggest a potential reduction in prolapse recurrence with combined repair. Robotic platforms, including newer systems, enhance precision, and visualization. Emerging techniques include laparoscopic resection rectopexy with SCP and selective use of biologic mesh. Multidisciplinary care improves coordination and recurrence prevention.</p><p><strong>Summary: </strong>Contemporary management of multicompartment prolapse requires a collaborative, patient-centered approach. Advances in imaging and minimally invasive surgery, particularly robotic SCP and VMR, have improved outcomes. Future research should focus on standardizing techniques, optimizing mesh configurations, and long-term functional results.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"416-420"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Obstetrics & Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1